Dacomitinib
Dacomitinib is an anticancer drug (EGFR inhibitor).
| Catalog Number | API0232656 |
| Alternative Name(s) | (E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide; 829-313-8 |
| Research Area | API |
| Molecular Formula | C24H25ClFN5O2 |
| CAS# | 1110813-31-4 |
| Inchi | InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+ |
| Inchi Key | LVXJQMNHJWSHET-AATRIKPKSA-N |
| SMILES | COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4 |
| Size | inquiry |
| Supplier Page | https://apihub.protheragen.ai/dacomitinib-item-1156.html |
